ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS

Get a Price/Quote

ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS Specification

Salt Composition
Erlotinib Hydrochloride

Dosage Form
Oral tablets

Origin of Medicine
Allopathic

Indication
Patients with metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer

Pacakaging (Quantity Per Box)
30 tablets per box

Drug Type
Prescription only

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Function
Anti-cancer (EGFR inhibitor)

Recommended For
Non-Small Cell Lung Cancer, Pancreatic Cancer

Dosage
150 mg once daily or as prescribed by physician

Dosage Guidelines
As directed by physician; swallow whole with water, do not crush or chew

Suitable For
Adults

Quantity
30 tablets

Storage Instructions
Store below 30C, protect from light and moisture

Storage Temperature
Below 30°C

Strength
150 mg

Instruction for Use
Take at least 1 hour before or 2 hours after meals

Shelf Life
24 months from manufacturing date

Brand Name
ERLOCIP 150

Color
White to off-white

Marketed By
Cipla Ltd.

Therapeutic Class
Antineoplastic agent (EGFR tyrosine kinase inhibitor)

ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS Trade Information

Packaging Details
PACK OF 30 TABLETS

About ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS

Erlocip 150 Mg Tablets - Erlotinib Hydrochloride

Erlocip Tablets Contains Erlotinib And Its Available As : 100 Mg & 150 Mg Tablets.

Specification :-

Product Name : Erlocip
Content : Erlotinib Hcl
Form : Tablets
Strength : 100 Mg & 150 Mg
Packing : Pack Of 30 Tablets
Manufactured By : Cipla

Note :- Erlocip Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Targeted Cancer Therapy

ERLOCIP 150 is specifically formulated as an EGFR inhibitor, helping to prevent the growth and spread of cancer cells. It targets metastatic non-small cell lung cancer and pancreatic cancer, offering tailored treatment where conventional therapies may not suffice. Administered once daily, ERLOCIP 150 delivers consistent anti-cancer action with proven outcomes in clinical practice.

Proper Usage and Handling

To ensure maximum benefit, swallow the tablet whole with water, ideally one hour before or two hours after eating. Do not crush or chew. Store at a temperature below 30C and protect from moisture and light to preserve its efficacy. Each box contains 30 tablets, making adherence to the prescribed regimen practical and straightforward.

FAQs of ERLOCIP 150MG ERLOTINIB HYDROCHLORIDE TABLETS:

Q: How should I take ERLOCIP 150MG tablets for best results?

A: Take ERLOCIP 150MG tablets at least one hour before or two hours after a meal, swallowing the tablet whole with plenty of water. Follow your physicians exact dosing instructions, and do not crush or chew the tablets.

Q: What conditions are ERLOCIP 150MG tablets recommended for?

A: ERLOCIP 150MG tablets are indicated for adults with metastatic non-small cell lung cancer (NSCLC) and pancreatic cancer, providing targeted therapy as an EGFR tyrosine kinase inhibitor.

Q: When and how often should I use ERLOCIP 150MG?

A: The typical dosage is 150 mg (one tablet) once daily, or as prescribed by your healthcare provider. Consistent daily intake at the same time each day can help maintain effective drug levels.

Q: Where should I store ERLOCIP 150MG tablets?

A: Store ERLOCIP 150MG tablets at a temperature below 30C, away from light and moisture. Keep them in their original packaging to preserve their quality.

Q: What is the shelf life of ERLOCIP 150MG Erlotinib Hydrochloride Tablets?

A: ERLOCIP 150MG tablets have a shelf life of 24 months from the manufacturing date, provided they are stored properly as directed.

Q: What are the benefits of using ERLOCIP 150MG in cancer treatment?

A: As an EGFR tyrosine kinase inhibitor, ERLOCIP 150MG can slow the growth of cancer cells and may improve outcomes for certain patients with NSCLC or pancreatic cancer.

Q: Who can prescribe ERLOCIP 150MG, and is it suitable for everyone?

A: ERLOCIP 150MG is a prescription-only medication recommended for adults. Its use should be supervised by an oncologist or physician experienced in cancer therapy and is not suitable for children or non-cancer indications.

Tell us about your requirement